Tagged with VAT

biotech Landsteiner is betting on biotech and genomics. The head of new developments and the head of genomic research share their views on the future of the company as well as the importance of embedding new technology in new product developments to better adapt to the changing needs of the Mexican…

innovation Innovation is a product’s added value, ensuring that the patient is ready to buy. The former director of R&D and today CEO of Carnot explains how the company is undergoing a process of professionalization with incremental innovation and exports as two of the company’s most important priorities. You have been…

innovation Induquímica is the only Peruvian pharmaceutical company with the “Marca Peru” emblem, a result of the company’s extremely high quality. General Manager Christian Quintanilla talks about the company’s success, and their unique strategy of relying on their reputation instead of using medical reps to sell their products. In what context…

MSD Guillermo Browne, Managing Director of MSD Peru, talks about the turnover of the affiliate and the company’s success in bringing new innovation to the country, particularly in the areas of vaccines and oncology. You arrived in Peru in January 2014. What initial tasks did you set for yourself? When I arrived, MSD…

biosimilars Christopher Ko was appointed as the Chief Executive Officer of Samsung Bioepis in 2012, then newly founded Korean pharmaceutical company with expertise in biosimilars. In this interview, he discusses the opportunities in Biosimilar markets as well as the potential impact the Samsung brand will bring to the pharmaceutical industry. As…

generics Carlos Leigh, executive president of Peru’s Asociación de Laboratorios Farmacéuticos Latinoamericanos (ALAFAL), discusses the advantages that LATAM companies have over big pharma players looking to enter the Peruvian market, and offers his predictions for the future of the sector for growth. Can you introduce yourself to our readers? I actively worked in…

innovation Lee Han-Koo, president of Daehwa Pharmaceutical, explains his strategy to corner the transdermal drug delivery system (TDDS) market through innovative patch products as well as a special focus on oral anticancer medication. Could you briefly introduce our readers to Daehwa? Daehwa was founded in January 1984 and listed on the…

healthcare “Argentina’s health system is in agony” In March 2002, amidst an economic crisis and national healthcare emergency the then Minister of Health Gines Gonzales Garcia declared “Argentina’s health system is in agony… What is lacking is money, not drugs. Our country has the best pharmaceutical industry in Latin America. The…

innovation Korean success story Boryung has a goal to become the number one domestic pharmaceutical company in the coming years. The company’s CEO, Choi Tae-Hong, discusses this strategy and the victory that their antihypertensive product Kanarb has brought in the Korean innovation game. You had a lengthy career at Janssen prior…

innovation Rodrigo Iturralde, general manager of Randall, walks us through the new plans of the company after a year of difficult yet enriching challenges and the ambitious goals set with an innovative strategy. Today generics represent 85 percent of the market in terms of volume, making Mexico one of the biggest…

transparency In 2014 the National Academy of Medicine celebrated its 150th anniversary. The president of the renowned medical institution discusses the recent activities of the academy, the importance of increasing transparency in the relationship between the pharmaceutical industry, healthcare institutions and physicians. This year the National Academy of Medicine celebrates its…

biotech Francisco Molinari, CEO of Argentina’s most sophisticated biotech group discusses Argentina’s competitiveness in the global biosimilar market, the current constraints limiting innovation in Argentina, and his company’s recent transition from an API producer to a fully integrated biosimilar developer and manufacturer. How would you describe the current state of the…